keyword
MENU ▼
Read by QxMD icon Read
search

Covert encephalopathy

keyword
https://www.readbyqxmd.com/read/27763575/optimal-treatment-of-hepatic-encephalopathy
#1
Sanath Allampati, Kevin D Mullen
Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome associated with decompensated liver disease. The spectrum of disease ranges from trivial abnormalities in complex decision-making and prolonged reaction time to coma in its most severe form. The very initial stages, recently termed covert hepatic encephalopathy, can only be diagnosed with the help of neuropsychiatric testing, while the later and more severe forms, termed overt hepatic encephalopathy, can be diagnosed clinically. Management of HE is very critical as it can dramatically increase morbidity and mortality...
December 2016: Minerva Gastroenterologica e Dietologica
https://www.readbyqxmd.com/read/27638475/urinary-metabolic-profiling-by-1-h-nmr-spectroscopy-in-patients-with-cirrhosis-may-discriminate-overt-but-not-covert-hepatic-encephalopathy
#2
Mark J W McPhail, Sara Montagnese, Manuela Villanova, Hamza El Hadi, Piero Amodio, Mary M E Crossey, Roger Williams, I Jane Cox, Simon D Taylor-Robinson
To date urinary metabolic profiling has been applied to define a specific metabolic fingerprint of hepatocellular carcinoma on a background of cirrhosis. Its utility for the stratification of other complications of cirrhosis, such as hepatic encephalopathy (HE), remains to be established. Urinary proton nuclear magnetic resonance ((1)H-NMR) spectra were acquired and NMR data from 52 patients with cirrhosis (35 male; 17 female, median (range) age [60 (18-81) years]) and 17 controls were compared. A sub-set of 45 patients (33 male; 12 female, [60 (18-90) years, median model for end stage liver disease (MELD) score 11 (7-27)]) were fully characterised by West-Haven criteria, Psychometric Hepatic Encephalopathy Score (PHES) and electroencephalogram (EEG), and defined as overt HE (OHE, n = 21), covert HE (cHE, n = 7) or no HE (n = 17)...
September 17, 2016: Metabolic Brain Disease
https://www.readbyqxmd.com/read/27571468/-hepatic-encephalopathy
#3
Davide Festi, Giovanni Marasco, Federico Ravaioli, Antonio Colecchia
Hepatic encephalopathy (HE) is a common complication of liver cirrhosis and it can manifest with a broad spectrum of neuropsychiatric abnormalities of varying severity, acuity and time course with important clinical implications. According to recent guidelines, HE has been classified into different types, depending on the severity of hepatic dysfunction, the presence of porto-systemic shunts and the number of previous episodes or persistent manifestations. From a clinical point of view, HE can be recognized as unimpaired, covert (that deals with minimal and grade 1 according to the grading of mental state), and overt (that is categorized from grade 2 to grade 4)...
July 2016: Recenti Progressi in Medicina
https://www.readbyqxmd.com/read/27448844/hepatic-encephalopathy-in-patients-with-non-cirrhotic-portal-hypertension-description-prevalence-and-risk-factors
#4
Valeria Nicoletti, Stefania Gioia, Pierleone Lucatelli, Silvia Nardelli, Chiara Pasquale, Stefano Nogas Sobrinho, Ilaria Pentassuglio, Francesca Greco, Adriano De Santis, Manuela Merli, Oliviero Riggio
BACKGROUND: Hepatic encephalopathy (HE) is a common complication of cirrhosis but it is less studied in patients with non-cirrhotic portal hypertension (NCPH). AIMS: To describe the prevalence of cognitive impairment (overt and covert HE) in NCPH patients and to identify the risk factors for its development. METHODS: 51 patients with NCPH, 35 with chronic portal vein thrombosis (PVT) and 16 with idiopathic non-cirrhotic portal hypertension (INCPH), were evaluated for the presence of previous or present overt HE (OHE)...
September 2016: Digestive and Liver Disease
https://www.readbyqxmd.com/read/27385440/stepwise-diagnosis-in-covert-hepatic-encephalopathy-critical-flicker-frequency-and-meld-score-as-a-first-step-approach
#5
R Greinert, C Ripoll, M Hollenbach, A Zipprich
BACKGROUND: The diagnosis of covert hepatic encephalopathy (CHE) by means of portosystemic encephalopathy syndrome (PSE) test is costly and therefore infrequently performed. AIM: To determine the ability of critical flicker frequency (CFF) alone or in combination with laboratory findings, as an initial test to pre-select which patients should undergo further testing for the diagnosis of covert hepatic encephalopathy. METHODS: This single-centre study included all patients with cirrhosis who underwent PSE and CFF in 2011...
September 2016: Alimentary Pharmacology & Therapeutics
https://www.readbyqxmd.com/read/27377741/evaluation-and-management-of-hepatic-encephalopathy-current-status-and-future-directions
#6
REVIEW
Duminda Suraweera, Vinay Sundaram, Sammy Saab
Hepatic encephalopathy is a spectrum of neurocognitive manifestations often seen in patients with liver injury or rarely in patients with portosystemic shunting without liver injury. It can be divided into minimal (covert) hepatic encephalopathy and overt hepatic encephalopathy, depending on the severity. Patients with hepatic encephalopathy have compromised clinical outcomes, decreased quality of life, and increased healthcare utilization, often resulting in a heavy financial and personal burden on caregivers...
July 15, 2016: Gut and Liver
https://www.readbyqxmd.com/read/27353278/factors-contributing-to-the-development-of-overt-encephalopathy-in-liver-cirrhosis-patients
#7
Motoh Iwasa, Ryosuke Sugimoto, Rumi Mifuji-Moroka, Nagisa Hara, Kyoko Yoshikawa, Hideaki Tanaka, Akiko Eguchi, Norihiko Yamamoto, Kazushi Sugimoto, Yoshinao Kobayashi, Hiroshi Hasegawa, Yoshiyuki Takei
The aim of this study was to clarify the relationships among psychometric testing results, blood ammonia (NH3) levels, electrolyte abnormalities, and degree of inflammation, and their associations with the development of overt hepatic encephalopathy (HE) in liver cirrhosis (LC) patients. The relationships between covert HE and blood NH3, sodium (Na), and C-reactive protein (CRP) were examined in 40 LC patients. The effects of elevated NH3, hyponatremia, and elevated CRP on the development of overt HE were also investigated...
October 2016: Metabolic Brain Disease
https://www.readbyqxmd.com/read/27255390/intracortical-inhibitory-and-excitatory-circuits-in-subjects-with-minimal-hepatic-encephalopathy-a-tms-study
#8
Raffaele Nardone, Pierpaolo De Blasi, Yvonne Höller, Francesco Brigo, Stefan Golaszewski, Vanessa N Frey, Andrea Orioli, Eugen Trinka
Minimal hepatic encephalopathy (MHE) is the earliest form of hepatic encephalopathy (HE) and affects up to 80 % of patients with liver cirrhosis. By definition, MHE is characterized by psychomotor slowing and subtle cognitive deficits,  but obvious clinical manifestations are lacking. Given its covert nature, MHE is often underdiagnosed. This study was aimed at detecting neurophysiological changes, as assessed by means of transcranial magnetic stimulation (TMS), involved in the early pathogenesis of the HE...
October 2016: Metabolic Brain Disease
https://www.readbyqxmd.com/read/27182210/contemporary-understanding-and-management-of-overt-and-covert-hepatic-encephalopathy
#9
Meghan NeSmith, Joseph Ahn, Steven L Flamm
Hepatic encephalopathy (HE) is a major complication of liver disease that leads to significant morbidity and mortality. Caring for hospitalized patients with HE is becoming more complex, and the economic burden of HE continues to rise. Defining and diagnosing HE, particularly covert HE (CHE), remain challenging. In this article, we review new tools and those currently under development for the diagnosis of CHE and the latest advances in the acute and long-term management of overt HE (OHE) and CHE. In particular, we review the latest data on the use of lactulose and rifaximin for treatment of OHE and summarize the data on adjunctive agents such as sodium benzoate and probiotics...
February 2016: Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/27158209/clinical-scenarios-for-the-use-of-s100%C3%AE-as-a-marker-of-hepatic-encephalopathy
#10
Andrés Duarte-Rojo, Astrid Ruiz-Margáin, Ricardo U Macias-Rodriguez, Francisco Javier Cubero, José Estradas-Trujillo, Rosa Ma Muñoz-Fuentes, Aldo Torre
AIM: To evaluate the association between serum concentrations of S100β in patients with cirrhosis and the presence of low grade hepatic encephalopathy (HE). METHODS: This was a cross-sectional study. The population was categorized into four groups healthy subjects, cirrhosis without HE, cirrhosis with covert hepatic encephalopathy (CHE) and cirrhosis with overt HE. Kruskal-Wallis, Mann Whitney's U with Bonferroni adjustment Spearman correlations and area under the ROC were used as appropriate...
May 7, 2016: World Journal of Gastroenterology: WJG
https://www.readbyqxmd.com/read/26925879/cognitive-impairment-predicts-the-occurrence-of-hepatic-encephalopathy-after-transjugular-intrahepatic-portosystemic-shunt
#11
Silvia Nardelli, Stefania Gioia, Chiara Pasquale, Ilaria Pentassuglio, Alessio Farcomeni, Manuela Merli, Filippo Maria Salvatori, Leandra Nikolli, Sabrina Torrisi, Francesca Greco, Valeria Nicoletti, Oliviero Riggio
OBJECTIVES: Hepatic encephalopathy (HE) is a major problem in patients treated with TIPS. The aim of the study was to establish whether pre-TIPS covert HE is an independent risk factor for the development of HE after TIPS. METHODS: Eighty-two consecutive cirrhotic patients submitted to TIPS were included. All patients underwent the PHES to identify those affected by covert HE before a TIPS. The incidence of the first episode of HE was estimated, taking into account the nature of the competing risks in the data (death or liver transplantation)...
April 2016: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/26866470/breathomics-exhaled-volatile-organic-compound-analysis-to-detect-hepatic-encephalopathy-a-pilot-study
#12
R P Arasaradnam, M McFarlane, K Ling, S Wurie, N O'Connell, C U Nwokolo, K D Bardhan, J Skinner, R S Savage, J A Covington
The current diagnostic challenge with diagnosing hepatic encephalopathy (HE) is identifying those with minimal HE as opposed to the more clinically apparent covert/overt HE. Rifaximin, is an effective therapy but earlier identification and treatment of HE could prevent liver disease progression and hospitalization. Our pilot study aimed to analyse breath samples of patients with different HE grades, and controls, using a portable electronic (e) nose. 42 patients were enrolled; 22 with HE and 20 controls. Bedside breath samples were captured and analysed using an uvFAIMS machine (portable e-nose)...
March 2016: Journal of Breath Research
https://www.readbyqxmd.com/read/26839918/er%C3%AE-signaling-is-required-for-trkb-mediated-hippocampal-neuroprotection-in-female-neonatal-mice-after-hypoxic-ischemic-encephalopathy-1-2-3
#13
Ulas Cikla, Vishal Chanana, Douglas B Kintner, Eshwar Udho, Jens Eickhoff, Wendy Sun, Stephanie Marquez, Lucia Covert, Arel Otles, Robert A Shapiro, Peter Ferrazzano, Raghu Vemuganti, Jon E Levine, Pelin Cengiz
Male neonate brains are more susceptible to the effects of perinatal asphyxia resulting in hypoxia and ischemia (HI)-related brain injury. The relative resistance of female neonatal brains to adverse consequences of HI suggests that there are sex-specific mechanisms that afford females greater neuroprotection and/or facilitates recovery post-HI. We hypothesized that HI preferentially induces estrogen receptor α (ERα) expression in female neonatal hippocampi and that ERα is coupled to Src family kinase (SFK) activation that in turn augments phosphorylation of the TrkB and thereby results in decreased apoptosis...
January 2016: ENeuro
https://www.readbyqxmd.com/read/26758861/recent-developments-in-the-diagnosis-and-treatment-of-covert-minimal-hepatic-encephalopathy
#14
M De Rui, S Montagnese, P Amodio
The terms minimal hepatic encephalopathy and covert hepatic encephalopathy are defined. Clinical assessment is unreliable and both require the use of diagnostic tools. Of these, psychometric tests are the most widely used. They require proper standardization and may be biased by patient cooperation or lack thereof. The measure of the critical flicker frequency and of the electroencephalogram, possibly quantified, are also useful. The alteration of any of them is not strictly parallel in size and may vary from patient to patient...
2016: Expert Review of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/26692331/advances-in-cirrhosis-optimizing-the-management-of-hepatic-encephalopathy
#15
REVIEW
Andy Liu, Ryan B Perumpail, Radhika Kumari, Zobair M Younossi, Robert J Wong, Aijaz Ahmed
Hepatic encephalopathy (HE) is a major complication of cirrhosis resulting in significant socioeconomic burden, morbidity, and mortality. HE can be further subdivided into covert HE (CHE) and overt HE (OHE). CHE is a subclinical, less severe manifestation of HE and requires psychometric testing for diagnosis. Due to the time consuming screening process and lack of standardized diagnostic criteria, CHE is frequently underdiagnosed despite its recognized role as a precursor to OHE. Screening for CHE with the availability of the Stroop test has provided a pragmatic method to promptly diagnose CHE...
December 18, 2015: World Journal of Hepatology
https://www.readbyqxmd.com/read/26563124/covert-hepatic-encephalopathy-elevated-total-glutathione-and-absence-of-brain-water-content-changes
#16
Georg Oeltzschner, Markus Butz, Frithjof Wickrath, Hans-Jörg Wittsack, Alfons Schnitzler
Recent pathophysiological models suggest that oxidative stress and hyperammonemia lead to a mild brain oedema in hepatic encephalopathy (HE). Glutathione (GSx) is a major cellular antioxidant and known to be involved in the interception of both. The aim of this work was to study total glutathione levels in covert HE (minimal HE and HE grade 1) and to investigate their relationship with local brain water content, levels of glutamine (Gln), myo-inositol (mI), neurotransmitter levels, critical flicker frequency (CFF), and blood ammonia...
June 2016: Metabolic Brain Disease
https://www.readbyqxmd.com/read/26446022/clinical-science-workshop-targeting-the-gut-liver-brain-axis
#17
Vishal C Patel, Helen White, Sidsel Støy, Jasmohan S Bajaj, Debbie L Shawcross
A clinical science workshop was held at the ISHEN meeting in London on Friday 11th September 2014 with the aim of thrashing out how we might translate what we know about the central role of the gut-liver-brain axis into targets which we can use in the treatment of hepatic encephalopathy (HE). This review summarises the integral role that inter-organ ammonia metabolism plays in the pathogenesis of HE with specific discussion of the roles that the small and large intestine, liver, brain, kidney and muscle assume in ammonia and glutamine metabolism...
October 8, 2015: Metabolic Brain Disease
https://www.readbyqxmd.com/read/26300936/impact-of-hepatitis-c-virus-infection-on-cognitive-function-in-patients-with-covert-hepatic-encephalopathy
#18
Farnaz Hashemi, Ali Fathi Ashtiani, Babak Mirminachi, Maryam Sharafkhah, Golnaz Ekhlasi, Elham Jafari, Hossein Poustchi
BACKGROUND: Liver cirrhosis has a significant impact on patient's quality of life and socioeconomic status and is associated with increased susceptibility to vehicle accidents and falls. OBJECTIVES: This study was conducted to evaluate cognitive function in patients with cirrhosis. PATIENTS AND METHODS: All subjects, who underwent transient elastography (TE) between March 2014 and August 2014 in Shariati outpatient clinic, Tehran, Iran, were enrolled in the study...
July 2015: Hepatitis Monthly
https://www.readbyqxmd.com/read/26195210/legal-responsibilities-of-physicians-when-they-diagnose-hepatic-encephalopathy
#19
REVIEW
John M Vierling
Both covert hepatic encephalopathy (CHE) and overt hepatic encephalopathy (OHE) impair the ability to operate machinery. The legal responsibilities of US physicians who diagnose and treat patients with hepatic encephalopathy vary among states. It is imperative that physicians know the laws regarding reporting in their state. OHE represents a neuropsychiatric impairment that meets general reporting criteria. The medical advisory boards of the states have not identified OHE as a reportable condition. In the absence of validated diagnostic guidelines, physicians are not obligated to perform tests for CHE...
August 2015: Clinics in Liver Disease
https://www.readbyqxmd.com/read/26195203/should-we-treat-minimal-covert-hepatic-encephalopathy-and-with-what
#20
REVIEW
Phillip K Henderson, Jorge L Herrera
Hepatic encephalopathy exists along a continuum from abnormal neuropsychiatric testing in the absence of clinical findings to varying degrees of detectable clinical findings. The International Society for Hepatic Encephalopathy and Nitrogen Metabolism has endorsed the term "covert" to encompass minimal hepatic encephalopathy and grade I overt hepatic encephalopathy. Covert hepatic encephalopathy has been associated with poor quality of life, decreased employment, increased falls, and increased traffic accidents that significantly impact quality of life and health care expenditures...
August 2015: Clinics in Liver Disease
keyword
keyword
84516
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"